Skip to contents
Karen Joynt, MD, MPH
Associate Physician, Brigham and Women's Hospital
Assistant Professor of Medicine, Harvard Medical School

Brigham and Women's Hospital
Department of Medicine
75 Francis Street
Boston, MA 02115

Edit Profile

Research Narrative:

My research interests are in three main areas: 1) Understanding variations in quality and efficiency between hospitals and health systems; 2) The impact of policy interventions on health care, with a focus on pay-for-performance and public reporting; and 3) Disparities in care, with a focus on minority-serving providers.  My published work thus far includes exploring how readmissions for heart failure differ between hospitals, examining racial and ethnic disparities in readmissions, and investigating differences between high- and low-volume, urban and rural hospitals.  My ongoing projects right now are around understanding the unique challenges faced by minority-serving hospitals in trying to reduce readmission rates, understanding the patterns of care and spending for the highest-cost patients in Medicare and Medicaid, and public reporting and its impact on case selection for PCI.  I’m currently developing a project to look at how ACOs impact cardiovascular care, outcomes, and costs.

Harvard School of Public Health, 2011, MPH
Harvard School of Public Health, 2010, MPH
Duke University School of Medicine, 2004, MD

Publications (Pulled from Harvard Catalyst Profiles):

1. Filice CE, Joynt KE. Examining Race and Ethnicity Information in Medicare Administrative Data. Med Care. 2017 12; 55(12):e170-e176.

2. Snyder JE, Jensen M, Nguyen NX, Filice CE, Joynt KE. Defining Rurality in Medicare Administrative Data. Med Care. 2017 12; 55(12):e164-e169.

3. Samson LW, Finegold K, Ahmed A, Jensen M, Filice CE, Joynt KE. Examining Measures of Income and Poverty in Medicare Administrative Data. Med Care. 2017 12; 55(12):e158-e163.

4. Gilstrap LG, Joynt KE. MACRA and Cardiology-The Devil Is in the Details. JAMA Cardiol. 2017 11 01; 2(11):1177-1178.

5. Joynt KE, Kramer DB. Off-label Use of High-Risk Cardiovascular Devices: Widening the Lens. JAMA Cardiol. 2017 08 01; 2(8):832-834.

6. Pandey A, Golwala H, Hall HM, Wang TY, Lu D, Xian Y, Chiswell K, Joynt KE, Goyal A, Das SR, Kumbhani D, Julien H, Fonarow GC, de Lemos JA. Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines. JAMA Cardiol. 2017 07 01; 2(7):723-731.

7. Joynt KE. Response to Outlier Status: Lessons From Public Reporting for Percutaneous Coronary Intervention. Circulation. 2017 05 16; 135(20):1908-1910.

8. Wadhera RK, Joynt KE. Insurance and Cardiovascular Health: Time for Evidence to Trump Politics. Circulation. 2017 05 23; 135(21):1988-1990.

9. Joynt KE, Zuckerman R, Epstein AM. Social Risk Factors and Performance Under Medicare's Value-Based Purchasing Programs. Circ Cardiovasc Qual Outcomes. 2017 05; 10(5).

10. Beaulieu ND, Joynt KE, Wild R, Jha AK. Concentration of high-cost patients in hospitals and markets. Am J Manag Care. 2017 Apr; 23(4):233-238.